title: Improved protection by recombinant BCG.
abstract: Mycobacterium bovis bacille Calmette Guérin (BCG) is one of the most widely used live vaccines. Technologic advancement in genome manipulation enables the construction of recombinant BCG (rBCG) strains, which can be employed as highly immunogenic vaccines against tuberculosis with improved safety profile.
authors.affiliation: Department of Immunology, Max-Planck Institute for Infection Biology, Schumannstr. 21/22, 10117 Berlin, Germany.
authors.forename: Ali
authors.initials: A
authors.lastname: Nasser Eddine
authors.forename: Stefan H E
authors.initials: SH
authors.lastname: Kaufmann
mesh_terms: D001500:BCG Vaccine / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D014376:Tuberculosis / Q000517:prevention & control*; D014614:Vaccines, Synthetic / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D001500:BCG Vaccine; D014614:Vaccines, Synthetic